Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro

被引:102
作者
Carter, Sally L. [1 ]
Mueller, Marcus [1 ]
Manders, Peter M. [1 ]
Campbell, Iain L. [1 ]
机构
[1] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia
关键词
chemokine; glia; inflammation;
D O I
10.1002/glia.20587
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The chemokines CXCL9 and CXCL10 bind to the common receptor CXCR3 and are implicated in the pathogenesis of T-cell-mediated immunity in the central nervous system (CNS). Here we examined the temporal and spatial regulation of the Cxc19 and Cxcl10 genes in the CNS of mice with myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) and by glial cells in vitro. During peak disease the levels of CXCL9 and CXCL10 mRNA and protein were increased significantly in the cerebellum and spinal cord but were reduced during the recovery phase. Expression of these genes in the CNS was abolished in IFN-gamma-receptor deficient mice with MOGEAE. In wild-type mice, CXCL9 RNA was localized mainly to infiltrating mononuclear cells including lesion and perilesional microglia, while CXCL10 RNA was seen primarily in more distal astrocytes that surrounded the inflammatory lesions. Examination of cultured glia following treatment with IFN-gamma revealed that while both CXCL9 and CXCLIO mRNA transcripts were induced in microglia, only CXCL10 mRNA was induced in astrocytes. Thus, although IFN-gamma is the pivotal mediator of both Cxcl10 and Cxcl9 gene expression in EAE, this cytokine differentially regulates the expression of these genes by astrocytes and microglia. The differential glial localization of these chemokines in EAE suggests CXCL9 and CXCL10 have specialized functions. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1728 / 1739
页数:12
相关论文
共 59 条
[1]   Chemokines in autoimmune diseases [J].
Arimilli, S ;
Ferlin, W ;
Solvason, N ;
Deshpande, S ;
Howard, M ;
Mocci, S .
IMMUNOLOGICAL REVIEWS, 2000, 177 :43-51
[2]   C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system [J].
Asensio, VC ;
Lassmann, S ;
Pagenstecher, A ;
Steffensen, SC ;
Henriksen, SJ ;
Campbell, IL .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :1181-1191
[3]   Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro [J].
Asensio, VC ;
Maier, J ;
Milner, R ;
Boztug, K ;
Kincaid, C ;
Moulard, M ;
Phillipson, C ;
Lindsley, K ;
Krucker, T ;
Fox, HS ;
Campbell, IL .
JOURNAL OF VIROLOGY, 2001, 75 (15) :7067-7077
[4]   CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[5]  
Berger T, 1997, LAB INVEST, V76, P355
[6]   Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia [J].
Biber, K ;
Dijkstra, I ;
Trebst, C ;
De Groot, CJA ;
Ransohoff, RM ;
Boddeke, HWGM .
NEUROSCIENCE, 2002, 112 (03) :487-497
[7]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[8]  
Bressler J P, 1980, Dev Toxicol Environ Sci, V8, P187
[9]  
CAMPBELL IL, 1994, J IMMUNOL, V152, P716
[10]   Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].
Cole, KE ;
Strick, CA ;
Paradis, TJ ;
Ogborne, KT ;
Loetscher, M ;
Gladue, RP ;
Lin, W ;
Boyd, JG ;
Moser, B ;
Wood, DE ;
Sahagan, BG ;
Neote, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021